Amylyx Pharmaceuticals And 2 More Quality Growth Stocks

The Federal Reserve just lifted interest rates again to tackle stubborn inflation, which puts real pressure on weaker balance sheets and slow growing businesses. In this environment, investors may focus on companies that analysts expect to grow earnings solidly while keeping finances in reasonable shape. This article breaks down three such high potential US stocks from our quality growth list, explaining what sets each apart and where the key risks sit. The stocks covered below are just a sample from this idea, with the full screen surfacing another 285 US listed businesses where analysts expect healthy earnings growth and balance sheets that still look reasonably robust.